BamSEC and AlphaSense Join Forces
Learn More

DexCom Inc.

NASDAQ: DXCM    
Share price (11/21/24): $74.46    
Market cap (11/21/24): $29.1 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2023, Dexcom, Inc. (The “Company,” “We” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934: Our Common Stock
12/34/56
EX-4.1
from 8-K 102 pages Dexcom, Inc. 0.375% Convertible Senior Notes Due 2028 Indenture Dated as of May 5, 2023 U.S. Bank Trust Company, National Association, as Trustee
12/34/56
EX-4.5
from S-3ASR 33 pages Dexcom, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.4
from S-3ASR 5 pages Form of Debt Security
12/34/56
EX-4.04
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2020, Dexcom, Inc. (The “Company,” “We” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934: Our Common Stock
12/34/56
EX-4.1
from 8-K 101 pages Dexcom, Inc. 0.25% Convertible Senior Notes Due 2025 Indenture Dated as of May 14, 2020 U.S. Bank National Association, as Trustee
12/34/56
EX-4.04
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2019, Dexcom, Inc. (The “Company,” “We” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934: Our Common Stock
12/34/56
EX-4.1
from 8-K 100 pages Dexcom, Inc. 0.75% Convertible Senior Notes Due 2023 Indenture Dated as of November 30, 2018 U.S. Bank National Association, as Trustee
12/34/56
EX-4.5
from S-3ASR 33 pages Dexcom, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.4
from S-3ASR 5 pages Form of Debt Security
12/34/56
EX-4.1
from 8-K 100 pages Dexcom, Inc. 0.75% Convertible Senior Notes Due 2022 Indenture Dated as of May 12, 2017 U.S. Bank National Association, as Trustee
12/34/56
EX-4.02
from S-3ASR 13 pages This Common Stock Purchase Agreement (“Agreement”) Is Made as of August 27, 2015, by and Between Dexcom, Inc., a Delaware Corporation (The “Company”) and Google Life Sciences LLC (“Gls”). Capitalized Terms Used but Not Defined Herein Shall Have the Meanings Ascribed to Them in the Collaboration and License Agreement (As Defined Below)
12/34/56
EX-4.02
from 8-K 24 pages Registration Rights Agreement by and Between Dexcom, Inc., as Issuer and Piper Jaffray & Co. Dated as of March 9, 2007
12/34/56
EX-4.01
from 8-K 95 pages Dexcom, Inc., as Issuer and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of March 9, 2007 4.75% Convertible Senior Notes Due 2027
12/34/56
EX-4.03
from S-1/A 42 pages Rights Agreement Between Dexcom, Inc. and American Stock Transfer & Trust Company, as Rights Agent Dated as of , 2005
12/34/56
EX-4.01
from S-1/A 3 pages Color: This Proof Was Printed From a Digital File or Artwork on a Graphics Quality, Color Laser Printer. It Is a Good Representation of the Color as It Will Appear on the Final Product. However, It Is Not an Exact Color Rendition, and the Final Printed Product May Appear Slightly Different From the Proof Due to the Difference Between the Dyes and Printing Ink. Please Initial the Appropriate Selection for This Proof: Ok as Is Ok With Changes Make Changes and Send Another Proof
12/34/56
EX-4.02
from S-1 20 pages Dexcom, Inc. Second Amended and Restated Investors' Rights Agreement
12/34/56